Thrivent Financial for Lutherans’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
85,506
-857
-1% -$8.27K ﹤0.01% 1859
2026
Q1
$641K Sell
86,363
-2,543
-3% -$26.8K ﹤0.01% 2112
2025
Q4
$1.05M Sell
88,906
-4,288
-5% -$46.3K ﹤0.01% 1904
2025
Q3
$719K Sell
93,194
-1,437
-2% -$10.1K ﹤0.01% 1942
2025
Q2
$692K Buy
94,631
+347
+0.4% +$2.8K ﹤0.01% 1995
2025
Q1
$895K Sell
94,284
-4,933
-5% -$61.6K ﹤0.01% 1793
2024
Q4
$1.64M Sell
99,217
-1,424
-1% -$22.1K ﹤0.01% 1591
2024
Q3
$1.48M Sell
100,641
-5,379
-5% -$84.2K ﹤0.01% 1658
2024
Q2
$1.47M Sell
106,020
-4,559
-4% -$64.6K ﹤0.01% 1600
2024
Q1
$1.74M Sell
110,579
-3,003
-3% -$46.4K ﹤0.01% 1518
2023
Q4
$1.84M Sell
113,582
-3,126
-3% -$51.2K ﹤0.01% 1431
2023
Q3
$1.44M Sell
116,708
-5,337
-4% -$79.4K ﹤0.01% 1528
2023
Q2
$1.96M Sell
122,045
-3,123
-2% -$51.5K ﹤0.01% 1350
2023
Q1
$2.18M Sell
125,168
-4,387
-3% -$62.5K 0.01% 1246
2022
Q4
$1.2M Sell
129,555
-482
-0.4% -$4.49K ﹤0.01% 1614
2022
Q3
$1.12M Sell
130,037
-77,838
-37% -$773K ﹤0.01% 1617
2022
Q2
$1.7M Buy
207,875
+107,645
+107% +$1.03M ﹤0.01% 1334
2022
Q1
$1.22M Buy
100,230
+32
+0% +$673 ﹤0.01% 1701
2021
Q4
$3.42M Buy
100,198
+925
+0.9% +$36.2K 0.01% 1066
2021
Q3
$4.79M Buy
99,273
+2,868
+3% +$133K 0.01% 906
2021
Q2
$4.36M Buy
96,405
+343
+0.4% +$15.2K 0.01% 990
2021
Q1
$4.63M Buy
96,062
+4,160
+5% +$217K 0.01% 952
2020
Q4
$4.95M Buy
91,902
+334
+0.4% +$15.1K 0.01% 871
2020
Q3
$3.38M Sell
91,568
-333
-0.4% -$12.4K 0.01% 921
2020
Q2
$2.85M Buy
91,901
+4,398
+5% +$122K 0.01% 899
2020
Q1
$2.42M Buy
87,503
+4,368
+5% +$131K 0.01% 875
2019
Q4
$2.43M Buy
83,135
+614
+0.7% +$14.6K 0.01% 942
2019
Q3
$1.58M Buy
82,521
+2,496
+3% +$58.5K ﹤0.01% 1128
2019
Q2
$1.76M Buy
80,025
+8,936
+13% +$196K 0.01% 1078
2019
Q1
$1.45M Buy
+71,089
New +$1.24M ﹤0.01% 1122

Other funds holding NEO

Thrivent Financial for Lutherans's NEO Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its NeoGenomics (NEO) stake by 0.99% in Q2 2026, selling an estimated $8.27K and leaving 85,506 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1859.

Thrivent Financial for Lutherans first reported a position in NEO in Q1 2019 and has held it in 30 quarters since. The position peaked at $4.95M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Thrivent Financial for Lutherans held 85,506 shares of NeoGenomics worth $1.25M as of Q2 2026.
  • Thrivent Financial for Lutherans sold 857 NeoGenomics shares in Q2 2026, an estimated $8.27K.
  • NeoGenomics made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1859 holding.
  • Thrivent Financial for Lutherans first reported a position in NeoGenomics in Q1 2019 and has held it in 30 quarters since.
  • Thrivent Financial for Lutherans's NeoGenomics position peaked at $4.95M in Q4 2020.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.